Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production

類似資料

• PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
  著者:: Curran, Michael A., 等
  出版事項: (2010)
• Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin
  著者:: Curran, Michael A., 等
  出版事項: (2013)
• CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection
  著者:: Waitz, Rebecca, 等
  出版事項: (2012)
• Tumor Vaccines Expressing Flt3-Ligand Synergize with CTLA-4 Blockade to Reject Pre-Implanted Tumors
  著者:: Curran, Michael A., 等
  出版事項: (2009)
• Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
  著者:: vom Berg, Johannes, 等
  出版事項: (2013)